Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed early-phase tilt small index

Plague Vaccine: early-phase trial registry

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

Plague Vaccine: 1 US clinical trial tracked, none currently recruiting.

Plague Vaccine is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is DynPort Vaccine Company LLC, A GDIT Company, running 1 of these trials.

Enrollment posture brief

Registry condition plague-vaccine

OPEN 0 | RECR 0% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Plague Vaccine (this)0%
Open-enrollment share among volume-matched conditions near Plague Vaccine

Plague Vaccine has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Plague Vaccine on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Plague Vaccine is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on Plague Vaccine records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

rF1V vaccine (without Adjuvant) Biological
1 trials
rF1V vaccine (with Adjuvant) Biological
1 trials

US sites by state

Facility locations filed on Plague Vaccine trials. A trial with sites in several states counts in each.

Tennessee 1 trials
South Carolina 1 trials
New York 1 trials
North Carolina 1 trials
Missouri 1 trials
Maryland 1 trials
Kentucky 1 trials
Kansas 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Plague Vaccine page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Plague Vaccine condition card totals 1 registered trials; most-linked intervention rF1V vaccine (without Adjuvant); top US site state Tennessee. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.